Current issues in medically assisted reproduction and genetics in Europe: Research, clinical practice, ethics, legal issues and policy

Human Reproduction

Volumn 29, Issue 8, 2014, Pages 1603-1609

  Harper, Joyce ^a,b   Geraedts, Joep ^c   Borry, Pascal ^d   Cornel, Martina C ^e   Dondorp, Wybo J ^c   Gianaroli, Luca ^f   Harton, Gary ^g   Milachich, Tanya ^h   Kääriäinen, Helena ⁱ   Liebaers, Inge ^j   Morris, Michael ^k   Sequeiros, Jorge ^l   Sermon, Karen ^j   Shenfield, Françoise ^a   Skirton, Heather ^m   Soini, Sirpa ⁱ   Spits, Claudia ^j   Veiga, Anna ⁿ   Vermeesch, Joris Robert ^d   Viville, Stéphane ^o   De Wert, Guido ^c   Macek Jr , Milan ^p   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Centre for Reproductive and Genetic Health   (United Kingdom)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Reproductive Medicine Unit   (Italy)

^g UNIVERSITY OF KENT   (United Kingdom)

^h SAGBAL Hospital 'Dr Shterev'   (Bulgaria)

ⁱ NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^j VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^k SYNLAB ACADEMY   (Germany)

^l UNIVERSITY OF PORTO   (Portugal)

^m UNIVERSITY OF PLYMOUTH   (United Kingdom)

ⁿ INSTITUT UNIVERSITARI DEXEUS   (Spain)

^o CNRS   (France)

^p CHARLES UNIVERSITY   (Czech Republic)

more..

Author keywords

Assisted reproduction technology; European Society of Human Genetics; European Society of Human Reproduction and Embryology; IVF; Reproductive genetics

Indexed keywords

ACCREDITATION; ARTICLE; CLINICAL GENETICS; CLINICAL PRACTICE; EMBRYONIC STEM CELL; EPIGENETICS; EUROPE; EUROPEAN UNION; FEMALE INFERTILITY; FUNDING; GENETIC SCREENING; GENOME ANALYSIS; HUMAN; HUMAN GENETICS; INFERTILITY THERAPY; MALE INFERTILITY; MEDICAL ETHICS; MEDICOLEGAL ASPECT; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; POLICY; POPULATION GENETICS; PRENATAL DIAGNOSIS; REGENERATIVE MEDICINE; REPRODUCTION; ADVERSE EFFECTS; ETHICS; FEMALE; GENETICS; GENOMIC INSTABILITY; HEALTH CARE DELIVERY; LEGISLATION AND JURISPRUDENCE; MALE; MEDICAL GENETICS; MEDICAL SOCIETY; MEDICAL TOURISM; TRENDS;

ACCREDITATION; EMBRYONIC STEM CELLS; EPIGENOMICS; EUROPE; FEMALE; GENETICS, MEDICAL; GENOMIC INSTABILITY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; MEDICAL TOURISM; PREIMPLANTATION DIAGNOSIS; REPRODUCTIVE MEDICINE; REPRODUCTIVE TECHNIQUES, ASSISTED; SOCIETIES, MEDICAL;

EID: 84904346293     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu130     Document Type: Article

References (121)

1. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011;29:1132-1144.
2. ASHG-GC American Society of Human Genetics: Genetic counseling. Am J Hum Genet 1975 27: 240-242.
3. Baart EB, Martini E, van den Berg I, Macklon NS, Galjaard RJ, Fauser BC, Van Opstal D. Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF. Hum Reprod 2006;21:223-233.
4. Ben-David U, Kopper O, Benvenisty N. Expanding the boundaries of embryonic stem cells. Cell Stem Cell 2012;10:666-677.
5. Beysen D, De Paepe A, De Baere E. FOXL2 mutations and genomic rearrangements in BPES. Hum Mutat 2009;30:158-169.
6. Borry P, Howard H. DTCgenetic services: a look across the pond. Am J Bio eth 2008;8:14-16.
7. Borry P, Howard HC, Senecal K, Avard D. Direct-to-consumer genome scanning services. Also for children? Nat Rev Genet 2009;10:8.
8. Borry P, HowardHC, Senecal K,Avard D. Health-related direct-to-consumer genetic testing: a reviewof companies' policies with regard to genetic testing in minors. Fam Cancer 2010;9:51-59.
9. Bredenoord AL, Pennings G, Smeets HJ, de Wert G. Dealing with uncertainties: ethics of prenatal diagnosis and preimplantation genetic diagnosis to prevent mitochondrial disorders. Hum Reprod Update 2008; 14:83-94.
10. Brezina PR, Benner A, Rechitsky S, Kuliev A, Pomerantseva E, Pauling D, Kearns WG. Single-gene testing combined with single nucleotide polymorphism microarray preimplantation genetic diagnosis for aneuploidy: a novel approach in optimizing pregnancy outcome. Fertil Steril 2011;95:1786 e1785-1788.
11. Brown R, Harper J. The clinical benefit and safety of current and future assisted reproductive technology. Reprod Biomed Online 2012;25:108-117.
12. Cadman SM, Kim SH, Hu Y, Gonzalez-Martinez D, Bouloux PM. Molecular pathogenesis of Kallmann's syndrome. Horm Res 2007;67:231-242.
13. Calderon FR, Nelson L, Dobrowolski P, Sinitsyna I, Phansalkar A, Longo N, Pasquali M, Mao R. Combination of enzyme analysis, allele-specific PCR and sequencing to detect mutations in the GALT gene. J Inherit Metab Dis 2007;30:818.
14. Cobo A, Kuwayama M, Perez S, Ruiz A, Pellicer A, Remohi J. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril 2008;89:1657-1664.
15. CoE-Genet Healthcare. Council of Europe: Recommendation CM/ Rec(2010)11 of the Committee of Ministers to member states on the impact of genetics on the organisation of health care services and training of health professionals. https://wcd.coe.int/ViewDoc.jsp?id=1660977&Site=COE (20 January 2013, date last accessed) 2010.
16. Coe-Oviedo. Council of Europe : Convention for the protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine CETS No.: 164. http://conventions.coe.int/Treaty/Commun/QueVoulezVous.asp?NT=164&CL=ENG (20 January 2013, date last accessed) 1997.
17. CoE-PGD-PND. Council of Europe: Background Document on Preimplantation and Prenatal Genetic Testing. http://www.coe.int/t/dg3/healthbioethic/Source/ INF-2010-6-dpidpn-en.pdf (20 January 2013, date last accessed) 2011.
18. Daar JF, Brzyski RG. Genetic screening of sperm and oocyte donors: ethical and policy implications. JAMA 2009;302:1702-1704.
19. Delhanty JD, Griffin DK, Handyside AH, Harper J, Atkinson GH, Pieters MHWinston RM. Detection of aneuploidy and chromosomal mosaicism in human embryos during preimplantation sex determination by fluorescent in situ hybridisation, (FISH). Hum Mol Genet 1993; 2:1183-1185.
20. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010; 376:911-921.
21. De Wert G. Ethics of preimplantation genetic diagnosis: the case of preimplantation genetic diagnosis. In: Fauser BCJM et al. (eds). Molecular Biology in Reproductive Medicine. New York/London: Parthenon, 1999, 443-450.
22. DeWert GM, Dondorp WJ, Knoppers BM. Preconception care and genetic risk: ethical issues. J Commun Genet. 2012;3:221-228.
23. Dondorp W, de Wert G. Innovative reproductive technologies: risks and responsibilities. Hum Reprod 2011;26:1604-1608.
24. Dondorp WJ, de Wert GM. The 'thousand-dollar genome': an ethical exploration. Eur J Hum Genet 2013;21:S6-S26.
25. Dul EC, Groen H, van Ravenswaaij-Arts CM, Dijkhuizen T, van Echten-Arends J, Land JA. The prevalence of chromosomal abnormalities in subgroups of infertile men. Hum Reprod 2012;27:36-43.
26. Dumoulin JC, Land JA, Van Montfoort AP, Nelissen EC, Coonen E, Derhaag JG, Schreurs IL, Dunselman GA, Kester AD, Geraedts JP et al. Effect of in vitro culture of human embryos on birthweight of newborns. Hum Reprod 2010;25:605-612.
27. EASC and FEAM report on DTC GT. 2012; available at: http://www.easac.eu/ home/reports-and-statements/detail-view/article/direct-to-co.html
28. EC-Dir17. EuropeanCommission - COMMISSIONDIRECTIVE 2006/ 17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=OJ: L: 2006:038:0040:0052:EN:PDF (20 January 2013, date last accessed 2006.
29. EC-Dir23. European Commission - DIRECTIVE 2004/ 23/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=OJ: L: 2004:102:0048:0058:en:PDF (20 January 2013, date last accessed 2004.
30. EC-DIR24. European Commission - DIRECTIVE 2011/ 24/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 9 March 2011 on the application of patients' rights in cross-border healthcare. http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ: L: 2011:088:0045:0065:EN:PDF (20 January 2013, date last accessed) 2011.
31. EC-DIr86. European Commission COMMISSION DIRECTIVE 2006/ 86/ EC of 24 October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events andcertain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ: L: 2006:294:0032:0050:EN:PDF (20 January 2013, date last accessed) 2006.
32. EC-Dir98-IVD. European Commission-DIRECTIVE 98/79/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 October 1998 on in vitro diagnostic medical devices. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ: L: 1998:331:0001:0037:EN:PDF (20 January 2013, date last accessed) 1998.
33. ESHG-Minors. European Society of Human Genetics: Genetic testing in asymptomatic minors: Recommendations of the European Society ofHuman Genetics. Eur J Hum Genet 2009;17:720-721.
34. ESHRE-Capri. European Society of Human Reproduction and Embryology: genetic aspects of female reproduction, proceedings from the Capri Workshop Group. Hum Reprod Update 2008;14:293-307.
35. Ferlin A, Vinanzi C, Garolla A, Selice R, Zuccarello D, Cazzadore C, Foresta C. Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations. Clin Endocrinol (Oxf) 2006;65:606-610.
36. Finnstrom O, Kallen B, Lindam A, Nilsson E, Nygren KG, Olausson PO.Maternal and child outcome after in vitro fertilization-a review of 25 years of population-based data from Sweden. Acta Obstet Gynecol Scand 2011;90:494-500.
37. Foresta C, Ferlin A, Gianaroli L, Dallapiccola B. Guidelines for the appropriate use of genetic tests in infertile couples. Eur JHumGenet 2002;10:303-312.
38. Fragouli E,Wells D. Aneuploidy in the human blastocyst. Cytogenet Genome Res 2011;133:149-159.
39. Geraedts J, Montag M, Magli MC, Repping S, Handyside A, Staessen C, Harper J, Schmutzler A, Collins J, Goossens V et al. Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results. Hum Reprod 2011;26:3173-3180.
40. German Parliament. Gendiagnostikgesetz vom 31. Juli 2009 (BGBl. I S. 2529, 3672. http://www.gesetze-im-internet.de/bundesrecht/gendg/gesamt.pdf (20 January 2013, date last accessed) 2009.
41. Goossens V, Traeger-Synodinos J, Coonen E, De Rycke M, Moutou C, Pehlivan T, Derks-Smeets IA, Harton G. ESHRE PGD Consortium data collection XI: cycles from January to December 2008 with pregnancy follow-up to October 2009. Hum Reprod 2012;27:1887-1911.
42. Haddow JEPG. ACCE: a model process for evaluating data on emerging genetic tests. In: Khoury MLJ, BurkeW(eds) Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease Oxford University Press, 2003, 217-233.
43. Handyside AH, Xu K. Preimplantation genetic diagnosis comes of age. Semin Reprod Med 2012;30:255-258.
44. Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw MA, Griffin DK. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet 2010;47:651-658.
45. Harper JC, Harton G. The use of arrays in preimplantation genetic diagnosis and screening. Fertil Steril 2010;94:1173-1177.
46. Harper JC, Sengupta SB. Preimplantation genetic diagnosis: state of the art 2011. Hum Genet 2012;131:175-186.
47. Harper J, Coonen E, De Rycke M, Fiorentino F, Geraedts J, Goossens V, Harton G, Moutou C, Pehlivan Budak T, Renwick P et al. What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee. Hum Reprod 2010a;25:821-823.
48. Harper JC, Sengupta S, Vesela K, Thornhill A, Dequeker E, Coonen E, Morris MA. Accreditation of the PGD laboratory. Hum Reprod 2010b; 25:1051-1065.
49. Harper J, Magli MC, Lundin K, Barratt CL, Brison D. When and how shouldnewtechnology be introduced into the IVF laboratory?HumReprod 2012a;27:303-313.
50. Harper JC, Wilton L, Traeger-Synodinos J, Goossens V, Moutou C,SenGupta SB, Pehlivan Budak T, Renwick P, De Rycke M, Geraedts JP et al. The ESHRE PGD Consortium: 10 years of data collection. Hum Reprod Update 2012b;18:234-247.
51. Harper JC, Geraedts J, Borry P, Cornel MC, Dondorp W, Gianaroli L, Harton G, Milachich T, Kääriäinen H, Liebaers I et al. on behalf of ESHG, ESHRE and EuroGentest. Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. European Society of Human Genetics and European Society of Human Reproduction and Embryology. Eur J Hum Genet 2013;21:S1-21.
52. Harton G, Braude P, Lashwood A, Schmutzler A, Traeger-Synodinos J, Wilton L, Harper JC. ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. Hum Reprod 2011a;26:14-24.
53. Harton GL, De Rycke M, Fiorentino F, Moutou C, SenGupta S, Traeger-Synodinos J, Harper JC. ESHRE PGD consortium best practice guidelines for amplification-based PGD. Hum Reprod 2011b;26:33-40.
54. Harton GL, Harper JC, Coonen E, Pehlivan T, Vesela K, Wilton L. ESHRE PGD consortium best practice guidelines for fluorescence in situ hybridization-based PGD. Hum Reprod 2011c;26:25-32.
55. Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC. ESHRE PGD Consortium/Embryology Special Interest Group-best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod 2011d;26:41-46.
56. Hens K, Dondorp W, Handyside AH, Harper J, Newson AJ, Pennings G, Rehmann-Sutter C, de Wert G. Dynamics and ethics of comprehensive preimplantation genetic testing: a review of the challenges. Hum Reprod Update 2013;19:366-375. doi: 10.1093/humupd/dmt009.
57. Hodes-Wertz B, Grifo J, Ghadir S, Kaplan B, Laskin CA,Glassner M, Munne S. Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos. Fertil Steril 2012;98:675-680.
58. Howard HC, Borry P. Europe and direct-to-consumer genetic tests. Nat Rev Genet 2011;13:146; author reply 146.
59. Howard HC, Avard D, Borry P. Are the kids really all right? Direct-toconsumer genetic testing in children: are company policies clashing with professional norms? Eur J Hum Genet 2011;19:1122-1126.
60. Hu Z, Xia Y, Guo X, Dai J, Li H, Hu H, Jiang Y, Lu F, Wu Y, Yang X et al. A genome-wide association study in Chinese men identifies three risk loci for non-obstructive azoospermia. Nat Genet 2012;44:183-186.
61. Hughes IA,Werner R, Bunch T, Hiort O. Androgen insensitivity syndrome. Semin Reprod Med 2012;30:432-442.
62. Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle-will we get our wish? N Engl J Med 2008;358:105-107.
63. ISO15189. International Organization for Standardization: ISO15189:2012-Medical laboratories-Requirements for quality and competence. http://www.iso.org/iso/home/store/catalogue-ics/catalogue-detail-ics.htm? csnumber=56115 (20 January 2013, date last accessed) 2012.
64. Iwarsson E, Lundqvist M, Inzunza J, Ahrlund-Richter L, Sjoblom P, Lundkvist O, Simberg N, Nordenskjold M, Blennow E. A high degree of aneuploidy in frozen-thawed human preimplantation embryos. HumGenet 1999;104:376-382.
65. Jablonka E, Raz G. Transgenerational epigenetic inheritance: prevalence, mechanisms, and implications for the study of heredity and evolution. Q Rev Biol 2009;84:131-176.
66. Khosla S, Dean W, Brown D, Reik W, Feil R. Culture of preimplantation mouse embryos affects fetal development and the expression of imprinted genes. Biol Reprod 2001;64:918-926.
67. Kim HG, Bhagavath B, Layman LC. Clinical manifestations of impaired GnRH neuron development and function. Neurosignals 2008;16:165-182.
68. Koika V, Georgopoulos NA, Piouka A, Roupas ND, Karela A, Armeni AK, Katsantoni E, Panidis D. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome. Eur J Endocrinol 2012;166:695-702.
69. Kosova G, Scott NM, Niederberger C, Prins GS, Ober C. Genome-wide association study identifies candidate genes for male fertility traits in humans. Am J Hum Genet 2012;90:950-961.
70. Maiburg M, Repping S, Giltay J. The genetic origin of Klinefelter syndrome and its effect on spermatogenesis. Fertil Steril 2012;98:253-260.
71. Mastenbroek S, Twisk M, van der Veen F, Repping S. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update 2011;17:454-466.
72. McNamee K, Dawood F, Farquharson R. Recurrent miscarriage and thrombophilia: an update. Curr Opin Obstet Gynecol 2012;24:229-234.
73. Munne S, Grifo J, Cohen J,Weier HU. Chromosome abnormalities in human arrested preimplantation embryos: a multiple-probe FISH study.Am J Hum Genet 1994;55:150-159.
74. Munne S, Sandalinas M, Magli C, Gianaroli L, Cohen J, Warburton D. Increased rate of aneuploid embryos in young women with previous aneuploid conceptions. Prenat Diagn 2004;24:638-643.
75. Navarro-Costa P, Plancha CE, Goncalves J. Genetic dissection of the AZF regions of the human Y chromosome: thriller or filler for male(in)fertility? J Biomed Biotechnol 2010;2010:936569.
76. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D et al. Tumour evolution inferred by single-cell sequencing. Nature 2011;472:90-94.
77. Odom LN, Segars J. Imprinting disorders and assisted reproductive technology. Curr Opin Endocrinol Diabetes Obes 2010;17:517-522
78. OECD-QA Organisation for Economic Cooperation and Development-OECD Guidelines for Quality Assurance in Molecular Genetic Testing. www.oecd.org/dataoecd/43/6/38839788.pdf (20 January 2013, date last accessed) 2007.
79. Pastuszak AW, Lamb DJ. The genetics of male fertility-from basic science to clinical evaluation. J Androl 2012;33:1075-1084.
80. Patrat C, Bienvenu T, Janny L, Faure AK, Fauque P, Aknin-Seifer I, Davy C, Thiounn N, Jouannet P, Levy R. Clinical data and parenthood of 63 infertile and Y-microdeleted men. Fertil Steril 2010;93:822-832.
81. Pennings G, Mertes H. Ethical issues in infertility treatment. Best Pract Res Clin Obstet Gynaecol 2012;26:853-863.
82. Pennings G, deWert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE Task Force on Ethics and Law 14: equity of access to assisted reproductive technology. Hum Reprod 2008a;23:772-774.
83. Pennings G, deWert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE task force on ethics and law 15: cross-border reproductive care. Hum Reprod 2008b;23:2182-2184.
84. Persani L, Rossetti R, Cacciatore C. Genes involved in human premature ovarian failure. J Mol Endocrinol 2010;45:257-279.
85. Rahmioglu N, Missmer SA, Montgomery GW, Zondervan KT. Insights into assessing the genetics of endometriosis. Curr Obstet Gynecol Rep 2012; 1:124-137.
86. Reefhuis J, Honein MA, Schieve LA, Correa A, Hobbs CA, Rasmussen SA. Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod 2009;24:360-366.
87. Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, Strecker MN, Williams JL. A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report. J Genet Couns 2006; 15:77-83.
88. Rozen SG, Marszalek JD, Irenze K, Skaletsky H, Brown LG, Oates RD, Silber SJ, Ardlie K, Page DC. AZFc deletions and spermatogenic failure: a population-based survey of 20,000 Y chromosomes. Am J Hum Genet 2012;91:890-896.
89. Rull K, Nagirnaja L, Laan M. Genetics of recurrent miscarriage: challenges, current knowledge, future directions. Front Genet 2012;3:34.
90. Sato N. Genetics of male hypogonadotropic hypogonadism. Pediatr Endocrinol Rev 2012;10(Suppl. 1):110-125.
91. Scott RT Jr, Ferry K, Su J, Tao X, Scott K, Treff NR. Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. Fertil Steril 2012;97:870-875.
92. Scott RT Jr, Upham KM, Forman EJ, Hong KH, Scott KL, Taylor D, Tao X, Treff NR. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril 2013;100:697-703.
93. Shenfield F. Preimplantation genetic diagnosis in order to choose a saviour sibling. Gynaecol Obstet Gynaecol 2005;33:833-834.
94. Shenfield F, de Mouzon J, Pennings G, Ferraretti AP, Andersen AN, de Wert G, Goossens V. Cross border reproductive care in six European countries. Hum Reprod 2010;25:1361-1368.
95. Shenfield F, Pennings G, De Mouzon J, Ferraretti AP, Goossens V. ESHRE's good practice guide for cross-border reproductive care for centers and practitioners. Hum Reprod 2011;26:1625-1627.
96. Simoni M, Bakker E, Krausz C. EAA/EMQN best practice guidelines for molecular diagnosis of y-chromosomal microdeletions. State of the art 2004. Int J Androl 2004;27:240-249.
97. Simoni M, Tuttelmann F, Gromoll J, Nieschlag E. Clinical consequences of microdeletions of the Y chromosome: the extended Munster experience. Reprod Biomed Online 2008;16:289-303.
98. Soini S, Ibarreta D, Anastasiadou V, Ayme S, Braga S, Cornel M, Coviello DA, Evers-Kiebooms G, Geraedts J, Gianaroli L et al. The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issues. Eur J Hum Genet 2006; 14:588-645.
99. Spencer TE, Palmarini M. Application of next generation sequencing in mammalian embryogenomics: lessons learned from endogenous betaretroviruses of sheep. Anim Reprod Sci 2012;134:95-103.
100. Spits C, Mateizel I, Geens M, Mertzanidou A, Staessen C, Vandeskelde Y, Van der Elst J, Liebaers I, Sermon K. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol 2008;26:1361-1363.
101. Stahl PJ, Schlegel PN. Genetic evaluation of the azoospermic or severely oligozoospermic male. Curr Opin Obstet Gynecol 2012;24:221-228.
102. Su Y, Howard HC, Borry P. Users' motivations to purchase direct-toconsumer genome-wide testing: an exploratory study of personal stories. J Community Genet 2011;2:135-146.
103. Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, Nayak-Young S, Dwyer AA, Quinton R, Hall JE, Gusella JF et al. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci USA 2010;107:15140-15144.
104. The Nordic Committee on Bioethics and The Norwegian Biotechnology Advisory Board. Summary of Conference: Prenatal DiagnosisIndividuals and Society. 2010. http://ncbio.org/nordisk/arkiv/oslo-summary-final.pdf.
105. Tiscornia G, Vivas EL, Izpisua Belmonte JC. Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nat Med 2011; 17:1570-1576.
106. Tong ZB, Sullivan SD, Lawless LM, Vanderhoof V, Zachman K, Nelson LM. Five mutations of mitochondrial DNA polymerase-gamma (POLG) are not a prevalent etiology for spontaneous 46,XX primary ovarian insufficiency. Fertil Steril 2010;94:2932-2934.
107. Treff NR, Northrop LE, Kasabwala K, Su J, Levy B, Scott RT Jr. Single nucleotide polymorphism microarray-based concurrent screening of 24-chromosome aneuploidy and unbalanced translocations in preimplantation human embryos. Fertil Steril 2011;95:1606-1612. e1601-1602.
108. Tuttelmann F, Rajpert-De Meyts E, Nieschlag E, Simoni M. Gene polymorphisms and male infertility-a meta-analysis and literature review. Reprod Biomed Online 2007;15:643-658.
109. USA, C. f. D. C.ACCE Model Process for Evaluating Genetic Testing. http://www.cdc.gov/genomics/gtesting/ACCE/index.htm (20 January 2013, date last accessed) 2013.
110. van Echten-Arends J, Mastenbroek S, Sikkema-Raddatz B, Korevaar JC, Heineman MJ, van der Veen F, Repping S. Chromosomal mosaicism in human preimplantation embryos: a systematic review. Hum Reprod Update 2011;17:620-627.
111. Van Haute L, Spits C, Geens M, Seneca S, Sermon K. Human embryonic stem cells commonly display large mitochondrialDNAdeletions. Nat Biotechnol 2013;31:20-23.
112. van Montfoort AP, Hanssen LL, de Sutter P, Viville S, Geraedts JP, de Boer P. Assisted reproduction treatment and epigenetic inheritance. Hum Reprod Update 2012;18:171-197.
113. Vanneste E, Voet T, Le Caignec C, Ampe M, Konings P, Melotte C, Debrock S, Amyere M, Vikkula M, Schuit F et al. Chromosome instability is common in human cleavage-stage embryos. Nat Med 2009;15:577-583.
114. Vanneste E, Bittman L, Van der Aa N, Voet T, Vermeesch JR. New array approaches to explore single cells genomes. Front Genet 2012;3:44.
115. Velker BA, Denomme MM, Mann MR. Embryo culture and epigenetics. Methods Mol Biol 2012;912:399-421.
116. Willemen D, D'HoogheT, Knoops I,DeNeubourg D, Spiessens C. Does the European Union Tissues and Cells Directive improve quality in the in vitro fertilization laboratory? A case study in a tertiary referral center. Semin Reprod Med 2012;30:191-198.
117. Xu WM, Shi QX, ChenWY, Zhou CX, Ni Y, Rowlands DK, Yi Liu G, Zhu H, Ma ZG, Wang XF et al. Cystic fibrosis transmembrane conductance regulator is vital to sperm fertilizing capacity and male fertility. Proc Natl Acad Sci USA 2007;104:9816-9821.
118. Yang Z, Liu J, Collins GS, Salem SA, Liu X, Lyle SS, PeckAC, Sills ES, Salem RD. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet 2012;5:24.
119. Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C, Broadbent PJ, Robinson JJ, Wilmut I, Sinclair KD. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat Genet 2001;27:153-154.
120. Yu J, Chen Z, Ni Y, Li Z. CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis. Hum Reprod 2012;27:25-35.
121. Yuan GC. Linking genome to epigenome. Wiley Interdiscip Rev Syst Biol Med 2012;4:297-309.